
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Octagon is developing new medicines for autoimmune and inflammatory disease. The company is pioneering a selective immunomodulation approach based on glyco-immune checkpoint receptors that allows for precise targeting of disease-driving immune processes
Drug discovery,drug development,high throughput screening,autoimmunity,and inflammation
Octagon therapeutics operates in the Biotechnology research industry.
Octagon therapeutics's revenue is 11m - 100m
Octagon therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.